Molecular Diagnostics and Therapy LLP

Molecular Diagnostics and Therapy LLP - healthcare in Delhi, India. FY 2026 financials & compliance.
LLPIN AAI-5185 Incorporated 09 February 2017 ROC Delhi HQ Delhi, India
Active Limited Liability Partnership healthcare MSME · Medium
Data last updated
Revenue · FY 2023
₹26.49 Cr
▲ 21% YoY
Net loss · FY 2023
₹1.78 Cr
Net margin -6.7%
EBITDA · FY 2023
₹2.95 Cr
EBITDA margin 11.2%
Contribution obligation
₹8 Cr
As per LLP agreement
Open charges
₹78.95 Cr
Satisfied ₹26.46 Cr
LLP age
9 yrs
Est. 2017
Designated partners
5
As per MCA filings
Active GSTINs
2
GST registered

About Molecular Diagnostics and Therapy LLP

Data last updated:

Molecular Diagnostics and Therapy LLP is a limited liability partnership (LLP) based in Delhi, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 09 February 2017 and has been in existence for over 9 years.

The LLP is registered with the Registrar of Companies (ROC), Delhi, under LLPIN AAI-5185. Its GSTIN is 09AAOFV7637A1ZU (Uttar Pradesh). The LLP holds 2 GST registrations, all of them active.

The LLP has a total obligation of contribution of ₹8 Cr. It is led by designated partners including Nidhi Gupta and Mohit Gupta.

Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at 96 Saini Enclave, Delhi, India – 110092.

As per the financials filed for FY 2023, the LLP reported a revenue of ₹26.49 Cr, a growth of 21% compared to the previous year. For the same year it recorded a net loss of ₹1.78 Cr (net margin -6.7%) and EBITDA of ₹2.95 Cr (EBITDA margin 11.2%). Revenue has grown at a compounded annual rate (CAGR) of 41% over three years.

As per MCA filings, the LLP has open charges of ₹78.95 Cr and satisfied charges of ₹26.46 Cr on record. Court records list 1 case involving the LLP, including 1 filed by the LLP; 1 case is pending.

Molecular Diagnostics and Therapy LLP is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0013141).

Company details

LLPIN AAI-5185
Incorporation Date 09 February 2017
Total Obligation of Contribution ₹8 Cr
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
MSME Classification Medium
Udyam Registration UDYAM-UP-29-0013141
Key People
Nidhi Gupta Designated Partner Mohit Gupta Partner Nikunj Jain Designated Partner

Recognitions & Rankings of Molecular Diagnostics and Therapy

MSME (Udyam registered) Ministry of MSME
Category
Medium (2023-24)
Udyam number
UDYAM-UP-29-0013141

Contact details

Molecular Diagnostics and Therapy LLP's registered office is in Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    96 Saini Enclave, Delhi, India – 110092
  • Industry
    Healthcare, Diagnostic Centers & Pathology Labs

To see the full contact details of Molecular Diagnostics and Therapy LLP, buy the company report.

Comprehensive company report
Molecular Diagnostics and Therapy LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Molecular Diagnostics and Therapy LLP

FY 2025 filings available

Molecular Diagnostics and Therapy LLP reported revenue of ₹26.49 Cr (up 21% YoY) for FY 2023.

Revenue · FY 2023
₹26.49 Cr ▲ 21%
Net loss · FY 2023
₹1.78 Cr margin -6.7%
EBITDA · FY 2023
₹2.95 Cr margin 11.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 21%
3 years · compounded
▲ 41%
EBITDA CAGR growth
1 year
▼ 33%
3 years · compounded
▼ 1%

Revenue has grown at a compounded annual rate (CAGR) of 41% over three years, including 21% growth in the latest year. EBITDA fell 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Income and Expenditure
Turnover
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax-₹1.78 Cr
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2022-23FY 2021-22FY 2020-21FY 2019-20FY 2018-19
Profitability
Net Profit Margin-6.7%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Molecular Diagnostics and Therapy LLP, buy the company report.

Designated partners of Molecular Diagnostics and Therapy LLP

Molecular Diagnostics and Therapy has 5 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Nidhi Gupta
Also directs: Virtuous Transactional Analytics Private Limited, Sarvid Projects LLP, Molecular Imaging Private Limited
Designated Partner11 Dec 20178 Years 10 MonthsCurrent
Mohit Gupta
Also directs: Industry Genome of India Private Limited, Virtuous Transactional Analytics Private Limited
Partner11 Dec 20178 Years 10 MonthsCurrent
Nikunj Jain
Also directs: Sarvid Projects LLP, Molecular Imaging Private Limited
Designated Partner11 Dec 20178 Years 10 MonthsCurrent
Aviral Gupta
Also directs: Molecular Foundation for Healthcare
Designated Partner12 Sep 20251 Years 1 MonthsCurrent
Nupur JainDesignated Partner12 Sep 20251 Years 1 MonthsCurrent
View all designated partners

Charges & borrowings

Open charges
₹78.95 Cr
Satisfied charges
₹26.46 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹25.00 Cr
Kotak Mahindra Bank Limited₹22.03 Cr
Axis Bank Limited₹18.56 Cr
Indusind Bank₹11.50 Cr
Yes Bank Limited₹1.86 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
12 Dec 2025101205249Yes Bank Limited₹1.86 CrOpen
21 Nov 2025101196887Hdfc Bank Limited₹25 CrOpen
18 Nov 2025101219130Axis Bank Limited₹18.56 CrOpen
28 May 2025101142891Kotak Mahindra Bank Limited₹22.03 CrOpen
30 Sep 2024101000540Indusind Bank₹4 CrOpen

To see the full charge records of Molecular Diagnostics and Therapy LLP, buy the company report.

Total charge records: 10 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Molecular Diagnostics and Therapy LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Molecular Diagnostics and Therapy has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
09AAOFV7637A1ZUUttar PradeshActive30 Jan 2018
07AAOFV7637A1ZYDelhiActive10 Jul 2021

To see the full GST registrations and return filing status of Molecular Diagnostics and Therapy LLP, buy the company report.

Recent activity

Molecular Diagnostics and Therapy LLP has 6 designated partner changes on record since 2017: 5 appointments and 1 cessation. The latest: Aviral Gupta was appointed as Designated Partner on 12 Sep 2025.

Charges
A charge with Yes Bank Limited amounted to Rs. 1.86 Cr with Charge ID 101205249 was registered on 12 Dec 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 25.00 Cr with Charge ID 101196887 was registered on 21 Nov 2025.
Charges
A charge with Axis Bank Limited amounted to Rs. 18.56 Cr with Charge ID 101219130 was registered on 18 Nov 2025.
Appointed
Aviral Gupta was appointed as Designated Partner.
Appointed
Nupur Jain was appointed as Designated Partner.
Ceased
Nupur Jain ceased to be Partner.
Charges
A charge with Kotak Mahindra Bank Limited amounted to Rs. 22.03 Cr with Charge ID 101142891 was registered on 28 May 2025.
AGM
Molecular Diagnostics And Therapy Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Molecular Diagnostics And Therapy Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Charges
A charge registered on 05 Mar 2021 via Charge ID 100445490 with Icici Bank Limited was fully satisfied on 20 Nov 2024.
Charges
A charge registered on 10 May 2018 via Charge ID 100185650 with Hdfc Bank Limited was fully satisfied on 13 Nov 2024.
Charges
A charge registered on 26 Jun 2019 via Charge ID 100282303 with Hdfc Bank Limited was fully satisfied on 25 Oct 2024.

13 earlier events are in the company report.

Frequently asked questions

Molecular Diagnostics and Therapy is an active limited liability partnership based in Delhi, India. The LLP works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 09 February 2017 (9+ years old) and is registered under LLPIN AAI-5185.

Molecular Diagnostics and Therapy has 5 current designated partners:

The latest financial statements of Molecular Diagnostics and Therapy on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.

The GSTIN of Molecular Diagnostics and Therapy is 09AAOFV7637A1ZU, registered in Uttar Pradesh. The LLP has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 07AAOFV7637A1ZY (Delhi).

The LLPIN (Limited Liability Partnership Identification Number) of Molecular Diagnostics and Therapy is AAI-5185. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Molecular Diagnostics and Therapy has 1 court case on record: 1 filed by the LLP. 1 is pending.

Molecular Diagnostics and Therapy was incorporated on 09 February 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.

Aviral Gupta was appointed as Designated Partner on 12 Sep 2025. Nupur Jain was appointed as Designated Partner on 12 Sep 2025. Nupur Jain ceased to be Partner on 11 Sep 2025. Molecular Diagnostics and Therapy has 6 designated partner changes on record in total.

Yes, Molecular Diagnostics and Therapy is registered as a medium enterprise under Udyam registration (number: UDYAM-UP-29-0013141).

The registered office of Molecular Diagnostics and Therapy is at 96 Saini Enclave, Delhi, India – 110092.